ACTIVE

LUCIMED

Export PDF

Financial year 2025 · Closed on 31/08/2025

Net result932,9 k €+382,7 %over 1 year

Gross margin1,5 M €+227,6 %over 1 year

Equity2,6 M €+54,9 %over 1 year

Workforce1,0 ETP-47,4 %over 1 year

Identity

Source · BCE/KBO

LUCIMED is a Public limited company incorporated in 2005. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Wavre. It employs on average 1,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0873.183.112
Incorporation: 14/04/2005
Legal form: Public limited company
Registered office: Rue de Genval 20
1301 Wavre · WallonieSee on map
Contributed capital: 190 000,00 €
Latest accounts: 31/08/2025
Average workforce: 1,0 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 93040Sports activities and amusement and recreation activities 96040Physical well-being activities 96230Other personal service activities 46460Wholesale of pharmaceutical goods+2

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 23 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	1,5 M €	+228%	456,6 k €	-18.0%	557 k €	+11.2%	501 k €	+19.5%	419,2 k €
EBITDA	1,4 M €	+324%	331,2 k €	-20.6%	417,3 k €	+3.2%	404,2 k €	+31.4%	307,6 k €
Operating result	1,4 M €	+355%	300,6 k €	-20.7%	379 k €	+17.2%	323,5 k €	+31.3%	246,4 k €
Net result	932,9 k €	+383%	193,3 k €	-27.1%	265 k €	+32.3%	200,3 k €	-16.3%	239,2 k €
Balance sheet
Equity	2,6 M €	+54.9%	1,7 M €	+12.8%	1,5 M €	+21.4%	1,2 M €	+19.3%	1 M €
Total assets	4,8 M €	+55.9%	3,1 M €	+15.6%	2,7 M €	+31.8%	2 M €	+61.7%	1,3 M €
Cash	531,2 k €	-44.0%	947,8 k €	+265%	259,7 k €	-29.2%	366,8 k €	-10.5%	409,8 k €
Debts	2 M €	+66.5%	1,2 M €	+11.5%	1,1 M €	+42.3%	762,4 k €	+337%	174,6 k €
Other
Workforce	1,0 ETP	-47.4%	1,9 ETP	-24.0%	2,5 ETP	-3.8%	2,6 ETP	+62.5%	1,6 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/08/2025

4 active · 4 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Eric DELLOYE	Chairman of the board of directors08/11/2023 → 08/11/2029Director01/04/2016 → 31/01/2022ended
EMMANUEL DELLOYE	Managing directorsince 02/08/2007Director31/01/2016 → 2021 accountsended
Jacques Tilman	Directorsince 08/04/2005
Monique TILMAN	Director

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Monique Lambinet	Director29/03/2011 → 31/01/2022

Other companies at this address

Rue de Genval 20 1301 Wavre

Company	CBE no.
A.A.R.S. Sud - All Asbestos Removal Services Sud● Active	0785.561.824
ATELIER D'ARCHITECTURE BRUNO ERPICUM & PARTENAIRES● Active	0464.240.614
CASYS● Active	0473.622.492
C+CURE OPERATIONS● Active	0438.246.889
CONTINENTAL CARBON COMPANY EUROPE● Active	0564.992.237
CREA-NESS● Active	0544.965.596
DELTA EURO EVENTS● Active	0892.964.677
DE RIDDER CONCEPTS● Liquidation	0460.470.183
ELC GREEN LABEL● Active	0541.629.588
ENVIRONNEMENT ET PROMOTION IMMOBILIERE● Active	0438.370.615
ERPICUM● Active	0437.540.670
FoxPeak● Active	1038.721.035
GALATE● Active	0457.277.992
GDS Real Estate● Active	0668.779.465
INTERNATIONAL SERVICES & ADVICES● Active	0433.068.079
JLC WOOD● Active	0464.484.104
MOS IMMO● Active	0698.840.755
MULLER SERVICES● Active	0876.896.925
NEJEN CONSULTING● Active	0817.538.170
OPTIMUM FINANCE● Active	0873.561.412

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/09/2024	01/09/2023	01/09/2022	01/09/2021	01/09/2020	01/09/2019
Closing of the financial year	31/08/2025	31/08/2024	31/08/2023	31/08/2022	31/08/2021	31/08/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/04/2026	05/05/2026	05/05/2026	06/06/2023	31/03/2022	28/04/2021
General meeting	02/03/2026	03/03/2025	04/03/2024	10/03/2023	11/03/2022	12/02/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 23 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/08/2025	02/03/2026	28/04/2026	French	PDF
Abridged modelCorrection	31/08/2024	03/03/2025	05/05/2026	French	PDF
Abridged modelCorrection	31/08/2024	03/03/2025	04/09/2025	French	PDF
Abridged model	31/08/2024	03/03/2025	25/06/2025	French	PDF
Abridged modelCorrection	31/08/2023	04/03/2024	05/05/2026	French	PDF
Abridged model	31/08/2023	04/03/2024	30/05/2024	French	PDF
Abridged model	31/08/2022	10/03/2023	06/06/2023	French	PDF
Abridged model	31/08/2021	11/03/2022	31/03/2022	French	PDF
Abridged model	31/08/2020	12/02/2021	28/04/2021	French	PDF
Abridged model	31/08/2019	18/03/2020	26/03/2020	French	PDF
Abridged model	31/08/2018	22/02/2019	27/09/2019	French	PDF
Abridged model	31/08/2017	26/02/2018	16/07/2018	French	PDF
Abridged model	31/08/2016	20/02/2017	28/04/2017	French	PDF
Abridged model	31/08/2015	05/02/2016	08/06/2016	French	PDF
Abridged model	31/08/2014	30/03/2015	31/07/2015	French	PDF
Abridged model	31/08/2013	21/04/2014	22/05/2014	French	PDF
Abridged model	31/08/2012	27/02/2013	22/05/2014	French	PDF
Abridged model	31/08/2011	23/01/2012	16/02/2012	French	PDF
Abridged model	31/08/2010	29/03/2011	31/03/2011	French	PDF
Abridged model	31/08/2009	26/02/2010	26/02/2010	French	PDF
Abridged model	31/08/2008	30/03/2009	30/03/2009	French	PDF
Abridged model	31/08/2007	28/01/2008	27/02/2008	French	PDF
Abridged model	31/08/2006	29/01/2007	15/02/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/08/2025

4 active · 4 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Eric DELLOYE	Chairman of the board of directors08/11/2023 → 08/11/2029Director01/04/2016 → 31/01/2022ended
EMMANUEL DELLOYE	Managing directorsince 02/08/2007Director31/01/2016 → 2021 accountsended
Jacques Tilman	Directorsince 08/04/2005
Monique TILMAN	Director

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Monique Lambinet	Director29/03/2011 → 31/01/2022

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Other14/11/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates01/04/2022
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Mandates08/12/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates02/05/2016
DEMISSIONS, NOMINATIONS
PDF
Mandates21/05/2014
DEMISSIONS, NOMINATIONS
PDF
Mandates06/04/2010
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Mandates03/09/2007
DEMISSIONS, NOMINATIONS
PDF
Registered office08/02/2007
SIEGE SOCIAL
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings19 filings

Mandates

Eric DELLOYE

Jacques TILMAN

Monique TILMAN

Emmanuel DELLOYE

MONIQUE LAMBINET

PHILIPPE MILLER

EMIL GALECTIC

MARCEL ESCHWEILER

20042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029

LUCIMED

Rue de Genval 20, 1301 Bierges

Chairman of the board of directorsDirector

Director

Managing directorDirector

Director

Managing directorDirector

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue de Genval 20, 1301 BiergesCurrent	accounts 2022 → 2025	Accounts 2025 · 2026-00093721

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
LUCIMEDCurrent	accounts 2024 → 2025	Accounts 2025 · 2026-00093721
LUCIMED (archived 13/05/2024 - 07:11)	accounts 2023	Accounts 2023 · 2024-00109555
LUCIMED	accounts 2022	Accounts 2022 · 2023-00114448

Events

2025
Annual accounts 2025932,9 k €↑
2024
Annual accounts 2024193,3 k €↓
2024
Name changeLUCIMED
2023
Annual accounts 2023265 k €↑
2023
Name changeLUCIMED (archived 13/05/2024 - 07:11)
2022
Annual accounts 2022200,3 k €↓
2021
Annual accounts 2021239,2 k €↓
2020
Annual accounts 2020253,2 k €↑
2019
Annual accounts 201915,2 k €↓
2018
Annual accounts 2018182,3 k €↓
2017
Annual accounts 2017195,1 k €↑
2016
Annual accounts 2016144,8 k €↑
2015
Annual accounts 20152,8 k €↓
2014
Annual accounts 20147 k €↓
2013
Annual accounts 201380,7 k €↑
2012
Annual accounts 20126,1 k €↓
2011
Annual accounts 201135,7 k €↑
2010
Annual accounts 2010-71,4 k €↓
2009
Annual accounts 200957,9 k €↑
2008
Annual accounts 200811,2 k €↑
2007
Annual accounts 2007-56,5 k €
14/04/2005
IncorporationPublic limited company

LUCIMED

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events